OSSB Pharma Fund
Status
Global HQ
Cranbury, New Jersey
Countries of investment
Investment stages
Industries
About
OSSB Pharma Fund OPEN SOURCE PHARMA FOUNDATION is a pioneering non-profit organization committed to transforming the pharmaceutical landscape by promoting open-source collaboration. By facilitating a platform where scientists, researchers, and pharmaceutical companies can exchange knowledge and resources, OSSB Pharma Fund seeks to enhance innovation and accessibility in drug development. The foundation's mission is to democratize pharmaceutical research, enabling diverse stakeholders to contribute to critical advancements in healthcare while fostering transparency and ethical practices within the industry. Through strategic partnerships and an inclusive approach, OSSB Pharma Fund aims to create a more sustainable and equitable future for global health.
OSSB Pharma Fund OPEN SOURCE PHARMA FOUNDATION is a pioneering non-profit organization committed to transforming the pharmaceutical landscape by promoting open-source collaboration. By facilitating a platform where scientists, researchers, and pharmaceutical companies can exchange knowledge and resources, OSSB Pharma Fund seeks to enhance innovation and accessibility in drug development. The foundation's mission is to democratize pharmaceutical research, enabling diverse stakeholders to contribute to critical advancements in healthcare while fostering transparency and ethical practices within the industry. Through strategic partnerships and an inclusive approach, OSSB Pharma Fund aims to create a more sustainable and equitable future for global health.
Investment Thesis
Manager's Experience
Bringing extensive expertise to the investment landscape, the fund manager has actively engaged in over 50 deals, primarily within the technology and healthcare sectors across North America and Europe. With a strong operator-first approach, they emphasize early-stage investments, leveraging deep industry insights to drive growth. Noteworthy exits include a successful IPO in the biotech field, showcasing their ability to identify and capitalize on emerging trends. Their data-driven strategy enables informed decision-making, positioning them as a significant player in the venture capital arena.